First Time Loading...

Oncotelic Therapeutics Inc
OTC:OTLC

Watchlist Manager
Oncotelic Therapeutics Inc Logo
Oncotelic Therapeutics Inc
OTC:OTLC
Watchlist
Price: 0.042 USD 2.94% Market Closed
Updated: Apr 27, 2024

Oncotelic Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oncotelic Therapeutics Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Oncotelic Therapeutics Inc
OTC:OTLC
Revenue
$70k
CAGR 3-Years
-66%
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

See Also

What is Oncotelic Therapeutics Inc's Revenue?
Revenue
70k USD

Based on the financial report for Sep 30, 2023, Oncotelic Therapeutics Inc's Revenue amounts to 70k USD.

What is Oncotelic Therapeutics Inc's Revenue growth rate?
Revenue CAGR 10Y
-7%

The average annual Revenue growth rates for Oncotelic Therapeutics Inc have been -66% over the past three years , and -7% over the past ten years .